Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q2 2024 (June 30)2holders −1
0new positions
1sold out
1famous investor
$54.99avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($2.0M) and Bank of America Corp. ($78). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
All 13F filers, Q1 2024 → Q2 2024: 3,723 shares bought and 193 shares sold, net +3,530 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Add +11.3% | 36,760 | $2.0M |
| Bank of America Corp. | — | Reduce -93.0% | 7 | $78 |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.